ICICI Prudential Nifty Pharma Index Fund
Direct · Growth ₹19.83
19 Oct 2026
NAV
22.0%
3Y CAGR
22.4%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
8.95
Sharpe
-16.6%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
0.38%
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹13.11 L | 23.9% | -13.5% | 73.5% |
| 3 Years | ₹36.00 L | ₹44.98 L | 15.3% | 9.0% | 19.0% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 23.9% | 14.3% | 5.8% | +9.7% |
| 3 Years | 15.3% | 11.0% | 12.0% | +4.3% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 23.5% | 15.8% | -8.4% | 63.1% | 0.85 | 4.92 | 90% | — | — |
| 3 Years | 22.0% | 21.7% | 18.9% | 26.9% | 8.95 | — | 100% | — | — |
-16.6%
Max Drawdown
5 mo
Drawdown Duration
14 mo
Recovery Time
-3.9%
Avg Drawdown
Calmar Ratio by Duration
1.42
1Y
1.33
3Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +18.70 | 0.53 | 64.9% | 38.7% | 16.8% | -9.5% |
| 3 Years | +13.53 | 0.59 | 73.8% | 54.1% | 19.4% | 5.5% |
| 5 Years | +9.69 | 0.56 | 71.1% | 50.0% | 15.3% | 4.8% |
| 7 Years | +5.89 | 0.56 | 71.1% | 50.0% | 10.7% | 3.4% |
| 10 Years | +3.16 | 0.56 | 71.1% | 50.0% | 7.4% | 2.4% |
| 12 Years | +2.12 | 0.56 | 71.1% | 50.0% | 6.1% | 2.0% |
| 15 Years | +1.10 | 0.56 | 71.1% | 50.0% | 4.8% | 1.6% |
19
Total Holdings
78.8%
Top 10 Weight
1
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 20.76% |
| 2 | Divi's Laboratories Ltd. | 11.88% |
| 3 | Cipla Ltd. | 7.83% |
| 4 | Laurus Labs Ltd. | 7.36% |
| 5 | Torrent Pharmaceuticals Ltd. | 7.34% |
| 6 | Dr. Reddy's Laboratories Ltd. | 6.95% |
| 7 | Lupin Ltd. | 5.25% |
| 8 | Aurobindo Pharma Ltd. | 4.69% |
| 9 | Glenmark Pharmaceuticals Ltd. | 3.69% |
| 10 | Alkem Laboratories Ltd. | 3.08% |